I see and read your post viridi and we, as shareholders
I see and read your post viridi and we, as shareholders wish we had experienced immunologists, virologists and hard nosed scientists but CYDY doesn't have the top rung of that kind of personnel. They have an ambitious CEO who cares so much for humanity and was willing to buy this molecule from Progenix (sp) and brought it to where we are now.
Sure, they're not as experienced as all of us would want from a CEO and BOD's but it's what we have and I'm proud to own shares in CYDY and was lucky to have brought my average cost down to .52 so yes, I am happy so far but Dr. P is so tenacious that I really believe that he will bring us over the finish line in due time but not as fast as more experience would have but it's what we have.
The goal posts have been moved so many times for CYDY and it does get frustrating but I have to believe DR. P and the BOD will get us over that goal line and by going overseas and circumventing the fda here in the US is IMO, a good move with all that's going on with, !!!!!!! you know who and I'm not going to repeat myself as you can see how I feel by my last couple of posts today so GLTU
HCIT
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...
Continue Reading
Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...
Continue Reading
Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...
Continue Reading
The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...
Continue Reading
Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...
Continue Reading
Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...
Continue Reading
Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...
Continue Reading
Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...
Continue Reading
Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...
Continue Reading
A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...
Continue Reading
Top 5 Most Recently Viewed Articles
Snail, Inc. Postpones Important Financial Call Snail, Inc. (NASDAQ: SNAL), a globally recognized developer and publisher of interactive digital entertainment, has officially announced the postponement of its much-anticipated conference call. This call, originally slated to discuss the company's financial outcomes for the second quarter ending June 30, has been delayed....
Continue Reading
The Mary S. Phipps Luncheon: A Celebration of Education This year marked a significant milestone as the inaugural Mary S. Phipps Luncheon for Education took place, embracing the legacy of a remarkable figure known for her unwavering commitment to education, leadership, and community service. Under the guidance of dedicated chairs, this event aimed to raise funds that...
Continue Reading
Silexion Therapeutics Makes Significant Progress in Cancer Research In an exciting development, Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company focused on RNA interference (RNAi) therapies, announced that their product SIL204 displayed remarkable activity against multiple human cancer cell lines characterized by various KRAS mutations....
Continue Reading
ClubLink Enhances Offerings with Deer Creek Purchase ClubLink Corporation ULC, the premier operator and manager of golf and country clubs in Canada, has recently made an exciting move by acquiring Deer Creek, a notable 45-hole golf and event complex. This impressive acquisition occurred for a substantial purchase price of $45,000,000, marking a significant growth...
Continue Reading
The Pivotal Year for AI Adoption As industries worldwide increasingly embrace artificial intelligence (AI), Evercore ISI points to 2025 as a transformative year for its adoption. The enthusiasm surrounding AI continues to escalate, yet clear indicators illustrate that widespread implementation has not yet reached full scale. Current Landscape of AI Adoption Despite a...
Continue Reading